Grant Pollock, MD
Urology · Kenner, LANPI 1740714302
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,400 of the $7,899 with a category attached, or 81.0%. Boston Scientific accounts for 95.3% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $6,740, more than ten times the $122 reported in 2019.
Across 33 payments — averaging $239.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Procept Biorobotics Corporation$171
- Coloplast$65
- Myriad Genetic Laboratories, Inc.$63
- Johnson & Johnson$36
- Urogen Pharma, Inc.$24
- plus $13 from 1 others
What the payments were for
- Speaking & faculty fees$6,40081%
- Travel & lodging$1582%
- Food & beverage$1,34017%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $7,526 |
| Procept Biorobotics Corporation | 1 | $171 |
| Coloplast | 1 | $65 |
| Myriad Genetic Laboratories, Inc. | 3 | $63 |
| Johnson & Johnson | 2 | $36 |
| Urogen Pharma, Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lumenis Pulse 120H$6,558
- AquaBeam Robotic System$171
- LithoVue$136
- AMS$122
- ACCUMAX$115
- GENERAL BPH$114
- Moses$109
How this compares
$7,899 in reported general payments places this provider in the 75th percentile of 199 urology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 40 | $23,251 |
| Tamsulosin Hcl | 184 | $1,804 |
| Oxybutynin Chloride ErOxybutynin Chloride | 121 | $1,516 |
| Finasteride | 69 | $773 |
| Bicalutamide | 14 | $252 |
| Ciprofloxacin Hcl | 27 | $152 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $70 |
| Meloxicam | 14 | $54 |
Paid to pharmacies, not to this prescriber.
Other urology in Kenner
- Michael MaddoxKenner$12K
- Richard VanlangendonckNew Orleans$289K
- Gerard HenryBossier City$256K
- Ralph HendersonShreveport$211K
- Wayne HellstromNew Orleans$183K
- Colin GoudelockeNew Orleans$124K
- Sunil PurohitCovington$99K
- Raju ThomasNew Orleans$67K
- Louis KraneNew Orleans$62K
- Kevin HebertShreveport$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.